Aneurysm clipping

Surgical approach

  • Usually pterional/frontotemporal craniotomy (common for anterior circulation aneurysms); other approaches (orbitozygomatic, interhemispheric, subtemporal, far-lateral) depending on aneurysm location
    • Head fixed in Mayfield pins, rotated/extended; microscope used
    • Dural opening → CSF drainage (cisternal opening) to relax brain; careful arachnoid dissection to expose aneurysm neck
  • Temporary arterial occlusion may be applied (temporary clip) to facilitate dissection/clip placement
    • Risk: focal ischaemia; duration minimised; sometimes repeated temporary occlusions
  • Definitive clip applied across aneurysm neck; patency of parent/branch vessels confirmed
    • Adjuncts: ICG angiography, micro-Doppler, intra-op DSA (centre dependent)
  • Potential for sudden rupture during dissection/clip application → rapid blood loss, raised ICP, need for controlled hypotension/temporary occlusion
    • Brain swelling may require osmotherapy, hyperventilation, ventricular drainage, or decompression

Anaesthetic management (overview)

  • Type of anaesthesia: General anaesthesia with controlled ventilation; neurophysiology monitoring may influence agent choice
    • TIVA (propofol/remifentanil) commonly used if MEP/SSEP monitoring; volatile acceptable in many cases at low MAC
  • Airway: ETT (cuffed) mandatory; avoid coughing/straining at induction/emergence
    • Consider reinforced tube; secure well (head turned, drapes, long case)
  • Duration: typically 3–8 hours (variable with complexity, rupture, intra-op angiography)
    • Expect prolonged immobility, fluid shifts, temperature management needs
  • Pain: moderate–severe (craniotomy, temporalis muscle); multimodal analgesia while enabling neuro assessment
    • Scalp block/local infiltration + paracetamol ± low-dose opioid; avoid oversedation
  • Monitoring/lines: invasive arterial line before induction if unstable/SAH; large-bore IV access; consider CVC if vasoactive infusions/poor access
    • Urinary catheter; temperature; neuromuscular monitoring; consider EEG/BIS if TIVA

Aims and key physiological principles

  • Prevent aneurysm rupture/re-rupture: avoid acute surges in MAP and ICP (especially at induction, pinning, incision, emergence)
  • Maintain cerebral perfusion: CPP = MAP − ICP; avoid hypotension (ischaemia) and hypertension (rupture/bleeding)
  • Optimise brain conditions: relaxed brain (low-normal PaCO2, osmotherapy when indicated), avoid venous congestion (head up, neutral neck, avoid tight ETT ties)
  • Enable rapid postoperative neurological assessment when appropriate (especially unruptured aneurysm or good-grade SAH)
  • Prevent secondary brain injury: normoxia, normocapnia/targeted mild hypocapnia, normoglycaemia, normothermia, treat seizures, avoid anaemia

Preoperative assessment

  • Ruptured vs unruptured aneurysm: ruptured = SAH physiology and complications; unruptured often elective with comorbidities (HTN, smoking)
  • SAH grading and implications: WFNS/Hunt–Hess (neuro status), Fisher grade (blood load → vasospasm risk)
    • Poor grade SAH: airway protection, ventilation, ICP issues, haemodynamic instability more likely
  • Complications to identify: hydrocephalus (EVD), raised ICP, rebleeding risk, vasospasm/DSCI, seizures, hyponatraemia (SIADH/CSW), cardiopulmonary dysfunction
    • SAH-related cardiac: ECG changes, troponin rise, stress cardiomyopathy, LV dysfunction; impacts induction/vasopressor choice
  • Medication: nimodipine (continue), anticonvulsants if prescribed; antiplatelets/anticoagulants (more relevant to coiling but may exist)
  • Baseline labs: FBC (Hb/platelets), U&E (Na+), coagulation, group & screen/crossmatch; consider ABG if ventilated/critically ill

Induction and airway

  • Goals: smooth induction, avoid hypertension/tachycardia and avoid hypotension; maintain oxygenation and normocapnia
  • Induction agents: propofol or thiopentone (both reduce CMRO2/CBF/ICP); consider haemodynamic reserve (SAH cardiomyopathy)
  • Blunt sympathetic response: opioid (fentanyl/alfentanil/remifentanil), lidocaine, short-acting beta-blocker (esmolol), vasodilator (GTN) as needed
  • Neuromuscular block: rocuronium/atracurium; avoid fasciculations and coughing/straining
  • Arterial line: often placed pre-induction in SAH/unstable; otherwise immediately post-induction before pinning

Maintenance: anaesthetic technique and monitoring

  • Technique: TIVA (propofol/remifentanil) or low-dose volatile + opioid; ensure immobility for microscope work and pin fixation
  • Ventilation: aim PaCO2 ~4.5–5.0 kPa; brief mild hypocapnia (e.g., 4.0–4.5) for brain relaxation if needed; avoid prolonged aggressive hyperventilation (ischaemia)
  • Oxygenation: avoid hypoxia; routine hyperoxia not required but ensure adequate PaO2 in SAH/vasospasm risk
  • Fluids: aim euvolaemia; isotonic crystalloids (0.9% saline or balanced isotonic solutions); avoid hypo-osmolar fluids and glucose-containing solutions (unless treating hypoglycaemia)
    • Colloids generally not required; blood products if significant haemorrhage/rupture
  • Blood pressure targets: individualised; avoid hypertension pre-clip; maintain adequate MAP/CPP, especially during temporary clipping and after definitive clipping
    • Have vasopressors ready (metaraminol/phenylephrine/noradrenaline) and vasodilators ready (GTN) depending on phase
  • Temperature: maintain normothermia; forced-air warming, fluid warming; avoid shivering post-op (raises ICP/MAP)
  • Neuro-monitoring: SSEP/MEP/EEG/processed EEG; adjust anaesthesia (TIVA, minimise volatile, avoid long-acting NMB if MEPs required)

Brain relaxation and ICP control

  • Position: head up ~15–30°, neutral venous drainage, avoid neck compression; ensure ETT ties and lines not obstructing jugular venous return
  • Osmotherapy: mannitol 0.25–1 g/kg or hypertonic saline (e.g., 3% or 7.5% per local protocol) when brain tight
    • Monitor serum Na+/osmolality and haemodynamics; mannitol causes diuresis and potential hypotension
  • CSF drainage: via EVD or lumbar drain (selected cases); coordinate with surgeon to avoid over-drainage and herniation risk
  • Hyperventilation: short-term rescue for acute brain swelling; avoid prolonged use (reduces CBF)
  • Steroids: not routinely indicated for aneurysm clipping (more for tumour/vasogenic oedema); follow local practice

Key intraoperative events and how to manage them

  • Mayfield pinning/scalp incision: intense sympathetic stimulus → treat with deepening anaesthesia, opioid bolus, local infiltration/scalp block, esmolol/vasodilator
  • Temporary clipping: risk of ischaemia → optimise CPP, avoid hypotension/anaemia/hypocapnia extremes; discuss planned duration; consider burst suppression only if requested/centre practice
  • Intraoperative rupture: call for help, inform surgeon, increase FiO2, secure large-bore access, rapid transfusion if needed, control BP (often lower MAP briefly), deepen anaesthesia, correct coagulopathy, prepare for sudden brain swelling
    • Avoid uncontrolled hypertension; avoid profound hypotension that jeopardises CPP—targets are phase- and surgeon-dependent
  • Acute brain swelling: check ventilation/PaCO2, head position/venous obstruction, consider osmotherapy, CSF drainage, deepen anaesthesia; exclude surgical causes (haematoma, venous infarct)
  • Seizures: treat with benzodiazepine/propofol, correct metabolic causes, consider levetiracetam/phenytoin per protocol; avoid hypoxia/hypercarbia

Emergence and postoperative care

  • Plan extubation vs postoperative ventilation based on: SAH grade, intra-op events (rupture, swelling), duration, hypothermia, haemodynamic instability, airway concerns
  • Smooth emergence: prevent coughing/straining (risk bleeding/raised ICP) using lidocaine, remifentanil tail, careful suctioning, antiemetics
  • Analgesia: paracetamol + scalp block/local; cautious opioids (small titrated doses); consider NSAIDs only if surgeon agrees and bleeding risk acceptable
  • PONV prophylaxis: high priority (vomiting increases ICP/MAP) → multimodal antiemetics
  • Post-op monitoring: HDU/ICU; frequent neuro observations; BP control; manage EVD if present; watch for vasospasm/DSCI, hydrocephalus, seizures, electrolyte disturbances
    • Nimodipine continued; treat suspected vasospasm with induced hypertension/euvolemia and endovascular therapy per neurocritical care pathway

Ruptured aneurysm (SAH) specifics

  • Rebleeding risk highest early; avoid hypertension and agitation; secure aneurysm early (clip/coil) where possible
  • Vasospasm/DSCI typically days 3–14; anaesthetic implications: maintain CPP, avoid hypovolaemia, treat hypotension promptly, avoid excessive hyperventilation
  • Hyponatraemia: SIADH vs cerebral salt wasting; treat according to volume status; avoid hypotonic fluids
  • Cardiopulmonary dysfunction: neurogenic stunned myocardium, pulmonary oedema; consider echo, cautious induction, noradrenaline often preferred to support CPP

Unruptured aneurysm specifics

  • Often elective: focus on comorbidities (HTN, IHD), antithrombotics, and smooth haemodynamics; aim for early wake-up and neuro exam
  • Blood pressure: avoid peri-induction hypertension; avoid hypotension that risks ischaemia during temporary clipping
You are anaesthetising a patient for clipping of a ruptured anterior communicating artery aneurysm. What are your main anaesthetic goals?

Structure around rupture prevention, cerebral perfusion, and brain relaxation.

  • Prevent re-rupture: avoid acute surges in MAP (induction, laryngoscopy, pinning, incision, emergence) and avoid rises in ICP (coughing, hypercarbia, obstruction to venous drainage)
  • Maintain cerebral perfusion: ensure adequate CPP (MAP − ICP); avoid hypotension, hypoxia, anaemia; treat hypotension promptly (often vasopressors required due to nimodipine/SAH physiology)
  • Optimise surgical conditions: relaxed brain (head up, normocapnia or mild hypocapnia if needed, osmotherapy/CSF drainage when indicated)
  • Avoid secondary brain injury: normoxia, normocapnia, normoglycaemia, normothermia; seizure control; manage sodium disturbances
  • Plan for postoperative care: extubation vs ventilation; smooth wake-up; ICU/HDU with neuro obs and vasospasm surveillance
How would you manage blood pressure during aneurysm surgery (before clip, during temporary clip, and after definitive clip)?

Targets are individualised and depend on rupture status, surgeon preference, and neuro-monitoring; describe principles and tools.

  • Pre-clip dissection: avoid hypertension (rupture risk) but maintain adequate CPP; use deep anaesthesia, remifentanil, esmolol; vasodilators (e.g., GTN) if needed
  • Temporary clipping: prioritise cerebral perfusion to collateral territories; avoid hypotension and anaemia; consider vasopressor infusion (noradrenaline/phenylephrine) to support MAP if required
  • After definitive clip: maintain stable MAP; treat hypertension (risk of bleeding/haematoma) and hypotension (ischaemia); ensure smooth emergence without coughing/straining
  • Always interpret BP relative to ICP/CPP and clinical context (EVD open/closed, brain swelling, vasospasm risk)
What methods can you use to achieve brain relaxation for craniotomy and aneurysm clipping?

List non-pharmacological and pharmacological measures; include risks.

  • Positioning/venous drainage: head up 15–30°, neutral neck, avoid jugular compression; ensure unobstructed venous return
  • Ventilation: normocapnia; short-term mild hypocapnia if needed; avoid prolonged aggressive hyperventilation (reduced CBF/ischaemia)
  • Osmotherapy: mannitol or hypertonic saline; monitor Na+/osmolality and haemodynamics; mannitol diuresis/hypotension
  • CSF drainage: EVD/lumbar drain (selected cases) with careful coordination to avoid over-drainage/herniation
  • Anaesthetic depth: adequate hypnosis/analgesia to prevent coughing/straining; consider propofol bolus for acute swelling
Describe your management of intraoperative aneurysm rupture.

This is a classic viva: prioritise communication, oxygenation, haemodynamic control, and resuscitation while enabling surgical control.

  • Immediate actions: call for help, inform surgeon, increase FiO2, check airway/ventilation, ensure anaesthetic depth and paralysis
  • Haemodynamics: rapidly control BP (often reduce MAP transiently if requested) while avoiding profound hypotension that compromises CPP; use titratable agents (remifentanil, GTN, vasopressors as needed)
  • Resuscitation: activate major haemorrhage if needed; rapid infusion, crossmatched blood, correct coagulopathy, maintain Hb appropriate for cerebral oxygen delivery
  • ICP/brain swelling: ensure head position/venous drainage; consider osmotherapy and short-term mild hyperventilation; coordinate CSF drainage if EVD present
  • After control: reassess ABG, Hb, coagulation, temperature; plan postoperative ventilation/CT and ICU
A patient with SAH is on nimodipine and becomes hypotensive during induction. How do you manage this and why?

Demonstrate understanding of CPP, nimodipine effects, and SAH cardiac dysfunction.

  • Recognise causes: vasodilation from anaesthetic agents + nimodipine, relative hypovolaemia, SAH-related myocardial dysfunction
  • Immediate management: reduce anaesthetic depth if appropriate, give fluid bolus if hypovolaemic, start vasopressor (metaraminol/phenylephrine) and escalate to noradrenaline infusion if persistent
  • Rationale: maintain CPP to prevent ischaemia/DSCI; hypotension is harmful in SAH
  • Further steps: consider echo/arterial waveform analysis, check Hb/ABG, review nimodipine dosing with ICU/neurosurgery (usually continue but may adjust temporarily)
What are the postoperative complications after aneurysm clipping that the anaesthetist should anticipate?

Cover neurological, cardiovascular, respiratory, and metabolic complications.

  • Neurological: intracranial haematoma, cerebral infarction (temporary clip/vasospasm), seizures, hydrocephalus, cranial nerve deficits
  • Vasospasm/DSCI (esp. days 3–14 after SAH): new focal deficit or reduced consciousness; requires urgent neurocritical care management
  • Cardiorespiratory: arrhythmias, myocardial dysfunction, pulmonary oedema/aspiration, ventilatory failure if poor grade SAH
  • Metabolic: hyponatraemia (SIADH/CSW), hyperglycaemia, temperature disturbance
  • General: PONV, pain, airway obstruction, venous thromboembolism risk (balance with bleeding risk)
Discuss the role of hyperventilation in aneurysm surgery.

Examiners want the balance: useful short-term, harmful if overused.

  • Mechanism: ↓PaCO2 → cerebral vasoconstriction → ↓CBF and ↓CBV → ↓ICP (temporary brain relaxation)
  • Indications: short-term rescue for acute brain swelling or to facilitate dural opening/critical dissection when requested
  • Risks: reduced CBF can precipitate ischaemia, especially in SAH/vasospasm or during temporary clipping; effect attenuates over time (CSF buffering)
  • Practical: aim normocapnia routinely; if used, mild hypocapnia and return to normocapnia once brain relaxed; use ABGs/ETCO2 correlation
How would you provide analgesia for aneurysm clipping while allowing early neurological assessment?

Show multimodal, opioid-sparing strategy and PONV prevention.

  • Local techniques: scalp block (supraorbital, supratrochlear, zygomaticotemporal, auriculotemporal, greater/lesser occipital) and wound infiltration
  • Systemic: paracetamol; small titrated opioid doses (e.g., fentanyl) or short-acting opioid strategy (remifentanil intra-op with careful transition)
  • Avoid excessive sedation/respiratory depression (hypercarbia → raised ICP; obscures neuro exam)
  • PONV prophylaxis: multimodal antiemetics to prevent vomiting/raised ICP

0 comments